Skip to main navigation

Skip to Content

Kinnate Investor Navigation

Overview
News & Events
- Press Releases
- Events & Presentations
Financial Information
- SEC Filings
Corporate Governance
Stock Information
Investor Resources

Price
Change

stock chart

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Investor Tools

Press Releases

Year

Kinnate Biopharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

Dec 07, 2020

Read More

Kinnate Biopharma Announces Pricing of Initial Public Offering

Dec 02, 2020

Read More

Kinnate Biopharma Appoints Dean J. Mitchell as Chairman of the Board

Sep 09, 2020

Read More

Kinnate Biopharma Closes $98 Million Series C Financing

Aug 26, 2020

Read More

Kinnate Biopharma Appoints Dr. Richard Williams as Chief Medical Officer

Jul 08, 2020

Read More

Kinnate Biopharma Appoints Nima Farzan as Chief Executive Officer

May 27, 2020

Read More

© 2021 Kinnate Biopharma

Kinnate Footer Legal

Terms of Use
Privacy